Actinium Appoints Lynn Bodarky as Chief Business Officer

/PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (Actinium or the Company), a leader in the development of targeted radiotherapies, today...

Related Keywords

,Sandesh Seth ,Lynn Bodarky ,Astellas Pharma ,Business Development Licensing ,University Of Pennsylvania ,Pharmacia Corporation ,Prnewswire Actinium Pharmaceuticals Inc ,Actinium Pharmaceuticals Inc ,Wharton School Of Business ,Columbia Business School ,Novartis ,Business Development At Geron Corporation ,Merck Co ,Global Head Of Business Development Operations ,Oncology Lg Chem Life Sciences ,Intrexon Corporation ,Actimaba National Cancer Institute ,Pfizer ,Marketing At Progenics Pharmaceuticals Inc ,Chief Business Officer ,Iomabb Phase ,Hifibio Therapeutics ,Senior Vice President ,Global Head ,Business Development ,Vice President ,Geron Corporation ,Progenics Pharmaceuticals ,Seattle Genetics ,Wharton School ,Actinium Pharmaceuticals ,National Cancer Institute ,Life Sciences ,Nc ,Health Care Amp Hospitals ,Medical Pharmaceuticals ,Pharmaceuticals ,Biotechnology ,Personnel Announcements ,